Hi, How Are You?
Forgot Password?
Sign Up
kalbe_med_lg_white
ID
  • Home
  • Article
  • Events
    All Events Webinar new!
  • Product & Disease
    Product Disease Pharmacovigilance Medical Calculator new!
  • Education
    MOOC CDK Multimedia
  • FAQ & Feedback
  • Diskusi
  • About Us
  • Login
  • Register
Articles
no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image no_image
Topics
All | Vitamin & Nutrition | COVID-19 | General Information | Cancer | Cardiology
Stem Cell
Wound Care
Vaccinology
Radiology
Obstetry and Gynecology
Family Medicine
Anesthesiology
Epidemiology
COVID-19
Cancer
Cardiology
Pediatric
Clinical Procedure
Common Diseases
Dental And Oral Health
Dermathology And Aesthetic
Drug
Endocrinology
Eyes
Female
Gastroenterology
General Information
Geriatry
Hematology
Hepatology
Allergy & Immunology
Infection Disease
Inflammation
Male
Mental Health
Mouth Ear Nose
Nephrology
Neurology
Pain
Pathology
Pulmonology
Skeletal & Muscle
Surgery & Recovery
Urology
Vitamin & Nutrition
SPECIAL COVERAGE Cancer
featured_img
Serplulimab Disetujui untuk Pengobatan Lini Pertama Kanker Paru Sel Kecil Stadium Ekstensif (ES-SCLC) di Uni Eropa
by dr. Dita Arccinirmala | 06 Februari 2025
Serplulimab adalah antibodi monoklonal (mAb) anti-PD-1 pertama di dunia yang disetujui di Uni Eropa untuk pengobatan lini pertama extensive stage small cell lung cancer (ES-SCLC). Serplulimab juga kini telah disetujui di Tiongkok, Eropa, dan beberapa negara Asia Tenggara, memberikan manfaat bagi lebih dari 90.000 pasien.
Harapan Baru untuk Pejuang Kanker Kolorektal Stadium Lanjut
by dr. Vivian Keung | 23 Oktober 2024
f875b2fd19382f248b560a87f3f650fa.jpg
Terapi Front Line Asciminib pada Pasien Leukemia Mieloid Kronik, Bagaimana Efektivitasnya?
by dr. Hastarita Lawrenti | 14 Oktober 2024
7e64ed877048e9a157cc89a9dd375088.jpg
Latest Articles
    Subscribe Status
    Home
    Article
    Products
    MOOC